Search results
Results from the WOW.Com Content Network
Acute lymphoblastic leukemia affected about 876,000 people globally in 2015 and resulted in about 111,000 deaths. [14] [10] It occurs most commonly in children, particularly those between the ages of two and five. [15] [4] In the United States it is the most common cause of cancer and death from cancer among children. [2]
Specialty: Hematology and oncology: Symptoms: Bleeding, bruising, fatigue, fever, increased risk of infections [2] Usual onset: All ages, [3] most common in 60s and 70s. [4] It is the most common malignant cancer in children, but the cure rates are also higher for them.
T-ALL is most prevalent in the adult population, but among paediatric cases, it has a median onset at age 9 and is most prominent in adolescents. [6] [10] The disease also exhibits a marked male predominance, with males having a three-fold increased risk of developing T-ALL compared to females. The reasons for T-ALL's higher incidence rates in ...
CLL is the most common type of leukemia in the Western world compared to non-Western regions such as Asia, Latin America, and Africa. [88] It is observed globally that males are twice as likely than females to acquire CLL. [88] CLL is primarily a disease of older adults, with 9 out of 10 cases occurring after the age of 50 years. [89]
Acute myeloid leukemia (AML) is a cancer of the myeloid line of blood cells, characterized by the rapid growth of abnormal cells that build up in the bone marrow and blood and interfere with normal blood cell production. [1] Symptoms may include feeling tired, shortness of breath, easy bruising and bleeding, and increased risk of infection. [1]
Adult T-cell leukemia/lymphoma (ATL or ATLL) is a rare cancer of the immune system's T-cells [1] [2] [3] caused by human T cell leukemia/lymphotropic virus type 1 . [4] All ATL cells contain integrated HTLV-1 provirus further supporting that causal role of the virus in the cause of the neoplasm. [ 4 ]
Acute leukemia or acute leukaemia is a family of serious medical conditions relating to an original diagnosis of leukemia. In most cases, these can be classified according to the lineage, myeloid or lymphoid , of the malignant cells that grow uncontrolled, but some are mixed and for those such an assignment is not possible.
In another study, the results showed that young age, normal karyotype and ALL induction therapy will have a better prognosis than Ph+, adult patients. The study shows median survival of children is 139 months versus 11 months of adults, 139 months for normal karyotype patients versus 8 months for ph+ patients. [13] [14]